Cancer immunotherapy has transformed the treatment landscape by helping the immune system recognize and attack tumors. At the ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

"Pancreatic cancer is what is known as a 'cold tumor,' meaning it has few infiltrated immune cells and therefore immunotherapy usually does not work," argues Rovira.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...

Integrated biomarker analyses confirm viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes ...

Oncolytics Biotech reveals promising survival data for pelareorep, an innovative immunotherapy, showing significant benefits ...

Penetrium™ Achieves Historic BreakthroughOvercoming Cold Tumor Failure and the Challenge of Metastatic Cancer in Immunotherapy and Antibody TherapyPresented at AACR 2025, Chicago ...

CHICAGO, May 7, 2025 /PRNewswire/ -- Hyundai Bioscience presented the results of its Penetrium™ combination preclinical studies at the 2025 American Association for Cancer Research (AACR) Annual ...